The Texas Alzheimer’s Research Consortium is a collaboration between five of the state’s leading medical research institutions to improve early diagnosis, treatment, and prevention of Alzheimer’s disease. Find out how you can become involved.
TARC to Study Alzheimer's Impact on Hispanics
The Texas Alzheimer's Research Consortium(TARC) is embarking on a new research focus on the impact of Alzheimer's disease on Hispanics and is adding a new partner institution -- The University of Texas Health Science Center at San Antonio -- to extend its research reach to South Texas.
The 81st Legislature authorized $6.85 million to fund the Consortium's work over the next two years. This funding will allow the TARC's five research institutions to expand their investigations into the genetic and blood biomarker links between Alzheimer's and inflammation, cardiovascular disease, homocysteine levels and diabetes. Hispanics' high incidence of heart disease and diabetes place them at high risk for Alzheimer's disease.
Justice Sandra Day O'Connor, who retired from the U.S. Supreme Court to care for her husband with Alzheimer's disease, praised Texas' leadership in Alzheimer's research during a state Capitol visit in April. Honored with a special Senate resolution, Justice O'Connor challenged the State and nation to pursue Alzheimer's breakthroughs with the same intensity that succeeded in curtailing polio and TB in the 1950s. Read More
TARC Research Updates
For Families & Caregivers
Alzheimer's News
TARC researchers document a simpler, more accurate way to measure smaller incremental changes in dementia progression. See TARC's findings in the Archives of Neurology.
Time is Key in Alzheimer's Research Dr. Rachelle Doody with Baylor College of Medicine describes how the Texas Alzheimer's Research Consortium intends to meet the AD challenge.
The 81st Legislature authorized $6.85 million to fund the Consortium's work over the next two years. This funding will allow 
Dr. Susan Rountree, Baylor College of Medicine